No paralogue variants have been mapped to residue 34 for KCNJ2.
| KCNJ2 | YSIV--SSEEDGM--KLATMAVANGF-GNG>K<SKVHTRQQCRSRFVKKDGHCNVQFINVGEK | 64 |
| KCNJ1 | DTLIRVLTESMFK--HLRK------W-VVT>-<R-FFGHSRQRARLVSKDGRCNIEFGNVEA- | 58 |
| KCNJ3 | VVTT--SSSGS----GLQPQG--PGQ-D-P>Q<QQLV-PKKKRQRFVDKNGRCNVQHGNLGSE | 63 |
| KCNJ4 | ----------------------------NG>Q<AHVP-RRKRRNRFVKKNGQCNVYFANLSNK | 38 |
| KCNJ5 | IGVT--PWDPKKIPKQARDYV--PIATD-R>T<RLLAEGKKPRQRYMEKSGKCNVHHGNVQ-E | 69 |
| KCNJ6 | SPVA--IHQP-KLPKQARDDL--PRHIS-R>D<R----TKRKIQRYVRKDGKCNVHHGNVR-E | 72 |
| KCNJ8 | YVLA--RIAA---------------E-NLR>K<P-RIRDRLPKARFIAKSGACNLAHKNIR-E | 52 |
| KCNJ9 | QENA--AFSP-------------------G>Q<E-EPPRRRGRQRYVEKDGRCNVQQGNVR-E | 40 |
| KCNJ10 | YSQT--TQTES------------------R>-<P-LMGPGIRRRRVLTKDGRSNVRMEHIADK | 47 |
| KCNJ11 | YVLT--RLA----------------E-DPA>K<P-RYRARQRRARFVSKKGNCNVAHKNIR-E | 51 |
| KCNJ12 | YSIV--SSEEDGL--HLVTMSGANGF-GNG>K<--VHTRRRCRNRFVKKNGQCNIEFANMDEK | 63 |
| KCNJ13 | ------MDSSNCK--VIAP------L-L-->-<------SQRYRRMVTKDGHSTLQMDGAQR- | 36 |
| KCNJ14 | SRAG--DEEEAGP--GLCRNGWAPAP-VQS>-<---P-VGRRRGRFVKKDGHCNVRFVNLGGQ | 69 |
| KCNJ15 | MSST--PLVKH------------------T>-<A-GAGLKANRPRVMSKSGHSNVRIDKVDGI | 46 |
| KCNJ16 | YHII--NADAKYP-----------GY-PPE>H<-IIAEKRRARRRLLHKDGSCNVYFKHIFGE | 53 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.K34R | c.101A>G | Putative Benign | SIFT: Polyphen: |